Transformation of acellular dermis matrix with dicalcium phosphate into 3D porous scaffold for bone regeneration

Abstract

Animal derived biomaterials have attracted much attentions in treating large size bone defect due to their excellent biocompatibility and potent bioactivities offered by the biomacromolecules and growth factors contained in these materials. Dermis-derived matrix (ADM) has been used as skin grafts and wound dressings for decades, however its application in bone tissue engineering has been largely limited as ADM possesses a dense structure which does not support bone tissue ingrowth. Recently, we have successfully fabricated porous scaffold structure using an ADM with the aid of micronization technique. When integrated with inorganic components such as calcium phosphate, ADM could be transformed to bone graft substitutes with desirable osteogenic properties. While purified and chemically cross-linked collagen has lost its natural structure, our ADM successfully preserved natural tropocollagen structure, as well as other bioactive components. A composite scaffold was fabricated by incorporating dicalcium phosphate (DCP) microparticles into ADM microfibers and freeze-dried to form a highly porous structure. Unlike conventional ADM materials, this scaffold possesses high porosity with interconnected pores. More importantly, our evaluation data demonstrated that it performed much more effective in treating critical bone defects in comparison with best commercial product on the market. In a head-to-head comparison with a commercial bone graft material Bongold^®, the ADM/DCP scaffold showed superior osteogenic capacity by filling the defect with well-organized new bone tissue in a rabbit radius segmental defect model. Put together, our results exhibited a novel bone graft substitute was developed by circumventing processing barriers associated with natural ADM, which offers another novel bone graft substitute for bone regeneration.

Keywords:

• Decellularized dermis
• dicalcium phosphate
• composite scaffold
• bone regeneration

Disclosure statement

Yongfeng Ran, Jingyi Zhang, Bo Li, Yuqing Zhu, Jiayu Chen, Qianhong He, Xin Chen, and Tao Jiang are employees of Hangzhou Huamai Medical Devices, Co., Ltd.

Additional information

Funding

This study was supported by the National Key R&D Program of China (2019YFA0110600 and 2018YFC1105404) and National Natural Science Foundation of China (31870959).